News Releases

  • UT Austin Expands Collaborative Research Efforts with Lockheed Martin in New Agreement

    The University of Texas at Austin and Lockheed Martin, a global aerospace and security company, today announced a collaborative research agreement to enhance engineering research collaboration and support cutting-edge university-led projects.

  • Two UT Austin Engineers Named Fellows of the National Academy of Inventors

    John B. Goodenough and Sidigata V. (S.V.) Sreenivasan of Cockrell School of Engineering at The University of Texas at Austin have been named fellows of the National Academy of Inventors (NAI), along with James W. McGinity of the College of Pharmacy.

  • UT Austin Engineers Develop First-Ever Capsule to Treat Hemophilia

    In the near future, hemophiliacs could be able to treat their disease by simply swallowing a capsule. Thanks to a breakthrough led by researchers in the Cockrell School of Engineering at The University of Texas at Austin, treatment for hemophilia can now be administered via a biodegradable system, a capsule, giving people affected by the hereditary bleeding disorder hope for a less expensive, less painful treatment option than conventional injections or infusions.

  • Cockrell School Honors Three Outstanding Young Engineering Graduates

    The Cockrell School's three Outstanding Young Engineering Graduates for 2016 are entrepreneurs, finance experts, CEOs and thought leaders in their fields. We honor them for their outstanding professional achievements, dedication to public service and support of higher education. Including this year's recipients, 31 alumni have been recognized with this award.

  • Flu Vaccine’s Effectiveness Can Be Improved, New Findings Suggest

    A team of engineers and scientists at The University of Texas at Austin is reporting new findings on how the influenza vaccine produces antibodies that protect against disease, research that suggests that the conventional flu vaccine can be improved. The findings were reported in the journal Nature Medicine on Nov. 7.